Procter & Gamble 10-Kyear ended 2026-06-30

Executive Summary

P&G’s FY2026 delivered modest sales growth but weaker operating profitability: organic sales rose just 1%, volume was flat, and earnings declined in every operating segment. Pricing, favorable currency movements and higher non-operating income supported headline results, while buybacks helped EPS rise despite broadly flat net earnings. Productivity savings are funding innovation and marketing, but have not fully offset investment, restructuring and input-cost pressures. The planned $3.8B Thorne acquisition adds a wellness growth opportunity; investors must weigh that expansion against weakening category economics, continued restructuring and substantial shareholder distributions.

Key Financial Highlights

• Earnings quality: Other non-operating income rose to $1.08B from $0.154B, including a $0.261B after-tax Glad disposal gain. P&G also recognized recovery of half of ≈$0.200B in potentially recoverable tariffs; these benefits are distinct from operating improvement.
• Cash conversion: OCF exceeded net earnings, with payables providing $0.919B and inventories consuming $0.641B. Capital expenditures rose 17% to $4.41B; FCF reflects OCF less capital expenditures, without management’s adjustments.
• Capital returns: Dividends consumed $10.2B and repurchases $5.03B. Shares outstanding declined 18.1M, or 0.8%, net of issuance; combined distributions slightly exceeded FCF.
• Financing: Balance-sheet debt totaled $34.1B; debt due within one year increased 19% to $11.3B. An undrawn $8.0B bank facility supports commercial paper, while current liabilities exceeded current assets by $12.5B.
• Intangible assets: Goodwill of $41.3B and net identifiable intangibles of $21.4B explain negative tangible equity and create exposure to valuation-driven write-downs.

Business Developments

P&G continues to emphasize differentiated products, packaging, marketing, retail execution and consumer value, with productivity savings intended to finance growth investment.

• Portfolio performance: Fabric & Home Care represents 35% of sales; its earnings fell 4% despite 2% sales growth. Beauty’s 5% organic growth was the strongest segment result, but earnings and market share declined; Baby, Feminine & Family Care organic sales fell 1%. Growth is not yet translating into stronger category economics.
• Restructuring: The productivity and portfolio program includes market and brand exits, supply-chain optimization and up to 7,000 non-manufacturing job reductions by FY2027. Expected pretax costs total $1.5B–$2.0B over two years; employees declined 4% to ≈104,000.
• Portfolio expansion: After year-end, P&G agreed on 8/4/2026 to acquire wellness and supplements brand Thorne for $3.8B, with closing anticipated in Q2 FY2027. The acquisition broadens its health-oriented portfolio but adds integration and capital-allocation demands.

Risk Assessment

• Demand and competition: Flat volume, share losses in several segments and pressure from private labels challenge P&G’s ability to sustain premium pricing.
• Costs and supply: Tariffs, commodities and product investment compressed gross margin; single-source suppliers and manufacturing sites amplify disruption risk.
• Currency and geopolitics: More than half of sales originate outside the United States, exposing earnings and supply chains to currency movements, trade restrictions and conflict.
• Retail concentration: Walmart represents ≈16% of sales and the top ten customers ≈43%; shelf-space losses or tougher commercial terms could materially affect results.
• Brand valuation: Gillette’s $12.8B indefinite-lived intangible remains impairment-sensitive; its latest tested fair value exceeded carrying value by more than 10%.
• Cybersecurity and product integrity: Reliance on global systems and third parties exposes operations to outages, data breaches and product-quality failures that could damage trusted brands.

Strategic Outlook and Investor Actionables

Management is betting that restructuring and product superiority can restore balanced growth, while Thorne opens another wellness avenue. The opportunity is stronger category demand and productivity; the threat is that spending, cost reductions and acquisitions fail to reverse margin pressure.

• Category recovery: Track Beauty’s 5% organic growth, Fabric & Home Care’s 1%, and Baby, Feminine & Family Care’s −1%. Improving growth alongside earnings and share would validate product investment; continued share losses would weaken the thesis.
• Thorne execution: The $3.8B acquisition succeeds if the acquired business grows within P&G; integration setbacks, disposal or impairment would signal failure.
• Restructuring payoff: Against $1.23B of FY2026 pretax charges and a 22.7% operating margin, later filings should show lower charges and margin recovery without sacrificing sales.
• Cash discipline: FCF of $15.1B slightly trailed dividends and repurchases. Stronger cash coverage would support distributions and expansion; persistent shortfalls would increase financing pressure.